Incretin-Related Therapies
in Diabetes: Virtual Grand Rounds

Webcast Series

The complex metabolic nature of type 2 diabetes presents ongoing, short- and long-term challenges for clinicians. Multifaceted, aggressive treatments are required to manage hyperglycemia, obesity, and patients' long-term health. Furthermore, the availability of novel pharmacotherapies has made treatment decisions for type 2 diabetes increasingly complicated.

In this series, current peer-reviewed literature will be used as a knowledge base from which findings will be translated for clinical application by expert faculty members, who will discuss individual patient case histories.

This Virtual Grand Rounds series will give clinicians an opportunity to hear expert opinion on the management of patients with type 2 diabetes, through case histories that encompass diverse treatment challenges.

2011 Sessions
	The Next Generation of Therapies for Type 2 Diabetes Lawrence Blonde, MD
	Estimated Time: 1 hour Release Date: December 27, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: December 27, 2012 Specialties: Endocrinologists, Primary Care Physicians, Internists
	Cardioprotection in Type 2 Diabetes: Role of Incretin–Related Therapies Carol Hatch Wysham, MD
	Estimated Time: 45 minutes Release Date: June 28, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: June 28, 2012 Specialties: Endocrinologists, Primary Care Physicians, Internists

Series Objectives

1. Describe the role of aggressive, multifaceted treatment approaches in providing glycemic control, targeting the underlying pathophysiology of type 2 diabetes, controlling weight, and reducing cardiovascular risks.
2. Recognize established CVD targets for patients with type 2 diabetes.
3. Assess consensus recommendations for therapy intensification.
4. Compare and contrast the mechanisms of action and clinical trial safety and efficacy data of available and emerging incretin therapies.
5. Apply appropriate CVD treatment strategies for patients with diabetes using virtual patient cases.
6. Evaluate how cardiovascular treatment strategies may apply to patients with type 2 diabetes.

Target Audience

This activity is directed to endocrinologists, primary care physicians, internists, and other health care professionals who manage and treat patients with type 2 diabetes.

Ask the Expert

Using the Ask the Expert portal, participants have the opportunity to submit questions about the case to the Activity Director, Charles Faiman, MD, FRCPC, MACE. To access this feature, begin the activity and enter your question(s) in the box at the bottom of the screen.